Chromax, a supplement for healthy and pre – diabetic, which promotes insulin health and improved blood sugar metabolism, cardiovascular disease, control cravings and fight weight gain, is now available through food, drug and mass retailers available nationwide. Develops Another chromium picolinate-based supplement by Nutrition 21 by Nutrition 21 Diachrome , a proprietary, non-prescription, insulin sensitizer for people with type 2 diabetes. Nationwide nationwide in selected drugstores. Nutrition 21 also markets Selenomax , a high selenium yeast supplement and stimulates the immune system protects by supporting antibody production and preventing free radical damage. Selenomax is at CVS / pharmacy in all its 6,200 stores across the country, including PharmaCare Specialty Pharmacy locations and the company is the exclusive importer of Icelandic fish oils, including omega-3 fatty acids, to to pharmaceutical standards and sold under the Iceland Health brand.
But separating out chromium picolinate, which provides very consistent results in studies as compared to other as compared to other chromium shows that at doses between 200-1000 mcg it a superior nutritional appendage is diabetes treatments. .. Is a greater clinical benefit in diabetes management than other forms of Chromium SupplementsNutrition 21, announced today that a peer-reviewed study was published on chromium picolinate in the latest issue of Diabetes Technology & Therapeutics. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels with type with type 2 diabetes. The review analyzed the research on chromium picolinate, supports the consistent beneficial effects chromium picolinate and refutes a previous review, the efficacy after combining results from all types of supplemental chromium analyzes.On BSD Medical Corp.BSD Medical Corp. Has the leading developer of systems can be used accurate precision focus heat treatments for cancer. Forward looking statements treatment used to treat Crab and to kill right increasing effectiveness of companion radiation therapy. Researchers have also shown promising results from which use of hyperthermia therapy combined with chemo and. For tumor reduction before surgery For other information, please visit on BSD Medical Web site or BSD patients Web site at.
– Add an international clinical study Denmark, Netherlands and Norway done with a 128 patients who have with recurrent or metastatic malignant melanoma patients hyperthermia therapy received together with radiotherapy had a complete response of recurrent malignant melanoma lesions out of 62 percent as compared to 35 percent for those received irradiations own, and local recurrence – free survival rates at 5 years was 46 percent to those who received both hyperthermia in and radiation and 28 percent for those that the radiation received only (See International Journal of hyperthermia that.
BSD Medical Corp.BSD Medical Corp.